A fungal metabolite, BMS-182123, which inhibited bacterial endotoxin-induced production of tumor necrosis factor (TNF-a) in murine macrophages and humanperipheral blood monocytes (in vitro), was isolated from the culture broth of Penicillium chrysogenumstrain V39673.The effective BMS-1 82123 concentration (IC50) resulting in 50% inhibition of lipopolysaccharide-induced TNF-a production in murine macrophages and humanmonocytes was 600 ng/ml and 4.0 jug/ml, respectively. BMS-182123 suppressed the lipopolysaccahride-induced TNF-a promoter activity and did not affect the stability of posttranscriptional mRNA. Addition of hydrophobic resin, Amberlite XAD-8(1 %), to the fermentation enhanced the production of BMS-182123by 5.5 fold. A total of 577mg pure BMS-182123 was recovered from a 250-liter fermentation supplemented with 1 %Amberlite XAD-8.
BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-a by Macrophages and Monocytes
(Received for publication August 30, 1995) A fungal metabolite, BMS-182123, which inhibited bacterial endotoxin-induced production of tumor necrosis factor (TNF-a) in murine macrophages and humanperipheral blood monocytes (in vitro), was isolated from the culture broth of Penicillium chrysogenumstrain V39673.The effective BMS-1 82123 concentration (IC50) resulting in 50% inhibition of lipopolysaccharide-induced TNF-a production in murine macrophages and humanmonocytes was 600 ng/ml and 4.0 jug/ml, respectively. BMS-182123 suppressed the lipopolysaccahride-induced TNF-a promoter activity and did not affect the stability of posttranscriptional mRNA. Addition of hydrophobic resin, Amberlite XAD-8(1 %), to the fermentation enhanced the production of BMS-182123by 5.5 fold. A total of 577mg pure BMS-182123 was recovered from a 250-liter fermentation supplemented with 1 %Amberlite XAD-8.
Tumor necrosis factor (TNF-a) is a pleiotropic cytokine produced primarily by monocytes/macrophages 1 '2*.
Unrestricted TNF-aproduction can lead to the induction of physiological shock. Lipopolysaccharide (LPS), which is present on the outer membrane of Gramnegative bacteria, is the most potent inducer of TNF-a production3A) and is one of the primary mediators in the cascade of inflammatory events resulting in endotoxic shock and death5~9). Therapeutic products under development for controlling the adverse effect of TNF-a include inhibitors, monoclonals, soluble receptors, immunoconjugates and immunomodulators6'10~13). In the course of our search for microbial metabolites that inhibit bacterial endotoxin-induced production of TNF-a in murine nracrophages and human peripheral blood monocytes, an active fungal metabolite was isolated from the culture of Penicillium chrysogenum strain V39673. In this paper, we report the taxonomy of the producing organism, fermentation, isolation and biological activities of BMS-182123.
Materials and Methods Fermentation
For production of BMS-182123in shake flask culture, 4ml'of the frozen stock of strain V39673 was used to inoculate a 500-ml Erlenmeyer flask containing 100 ml of vegetative medium consisting of 0.5% soluble starch, 0.5% glucose, 0. 1 % fishmeat extract, 0.1 % yeast extract, 0.2% NZ-case, 0.2% NaCl and 0.2% CaCO3. The seed MAR. 1996 culture was incubated at 28°C on a rotary shaker set at 250rpm. After 3 days, 4-ml aliquots of this seed culture were transferred to 500-ml Erlenmeyer flasks containing 100ml of the production medium composed of 2% glucose, 1% cornsteep liquor and 0.5% CaCO3. The production cultures were incubated at 28°C and 250 rpm for 3 days. For production in fermentor seed culture was inoculated into the production tank to yield a final concentration of 4% (v/v). Polypropylene glycol P-2000 was used as antifoam. The fermentation was carried out for 3~6 days under the following conditions: temperature, 28°C; agitation, 250rpm; and air flow, 0.9vol. per minute.
Extraction and Analytical Method
At various times during the production cycle, aliquots of the culture broth was removed from the fermentation and mixed with an equal volume ofbutanol for 1 hour.
After centrifugation, the butanol fraction was concentrated 10 fold and the production of BMS-182123 was monitored by HPLC using a C-18 //Bondapak column (3.9x300mm, Waters Associates) and UV absorption at 254nm. The solvent system was 0.1% H3PO4/CH3CN (35:65) with a flow rate of 1.5ml/ minute.
LPS Activation of the HumanTNF-a Promoter
The assay for the human TNF-apromoter activity was a modification of the protocol described by J. S. Economou et al.14) . A sequence of the human TNF-a promoter was excised (EcoRl/Ahall restriction sites) from a human TNF-a genomic clone, using standard laboratory methods15), to yield a 714 bp sequence (which 
LPS Induction of TNF-a from Thioglycolate Elicited
Murine Peritoneal Macrophages
To verify that the compound was also active with native macrophages, cultures were established using murine peritoneal macrophages. Outbred Swiss mice (25g) were injected (ip) with 2ml 4% brewers' thioglycolate medium(Difco). Four days later, the mice were sacrified and the cells recovered by standard peritoneal lavage techniques17*. The cells were washed and plated as described above. Stock 2x solutions of LPS were prepared at 400ng/ml in DMEM. Stock solutions of BMS-182123 (0.25~4mg/ml) were prepared in DMSO. BMS-182123effect on LPS induction ofcytotoxic TNF-a was determined as described above.
LPS Induction of TNF-a from HumanMonocytes
To determine whether BMS-182123 was active with human monocytes, cultures were established using enriched peripheral blood monocytes. for 2 hours, the culture supernatants were assayed for TNF-a using an ELISA (Endogen) specific for antigenic TNF-a. Northern Blot Analysis of TNF-a Message The quantitation of TNF-a messenger RNAwas determined using standard laboratory methods18'19*.
Equal amounts of RNAfrom each sample were blotted and probed using a 32P-labelled probe (5 GCTGACG-GTGTGGGTGAGGAGCACGTAGTC3 ) complementary to murine TNF-a mRNA.Autoradiograms were analyzed in an LKBUltrascan XL densitometer to establish relative amountsof TNF-amessage for each sample. To evaluate LPS induction of TNF-a message, macrophages cultures were incubated with LPS (1 A*g/ml) with and without BMS-182123 (2/xg/ml) for 4 hours and the RNA harvested and analysed. To determine the effects of BMS-182123 on TNF-a mRNAstability, the macrophages were first incubated with LPS (1 jug/ml) for culture of P. chrysogenum strain V39673 supplemented with 1% Amberlite XAD-8 is summarized in Fig. 2 .
Results

Taxonomy
The results on taxonomic studies performed on strain 15.7/xg/ml. The time course of BMS-182123 production is shown in Table 1 . There was a significant drop in the titer of BMS-182123 after 3 days of fermentation. The titer of BMS-182123 dropped from 15.7/jg/ml at day 3 to 0.1/ig/ml at day 5. It is evident that BMS-182123 was further metabolized and degraded after day 3 of the fermentation. Since addition of hydrophobic resins to the fermentation of several unstable antibiotics led to an increase in production of these secondary metabolites22~24), the effect of hydrophobic resins on the production of BMS-182123 in the fermentation was examined. Various hydrophobic resins (1 %) were added to the cultures of strain V39673 at 48 hours of the production cycle and the result is summarized in Table  2 . With the exception of Amberlite XAD-2resin, the production of BMS-182123 in the resin-supplemented cultures was 2. 1~4.0 fold higher than that of the control culture. Among the 5 resins tested, Amberlite XAD-8
was the best resin in enhancing the production of BMS-182123 with the titer of 53.7^g/ml. Since the time of addition of resin to the fermentation for titer improvement is also an important factor22'25*, Amberlite XAD-8resin was added to the fermentation either at 24, 48 or 72 hours to determine the optimal time of addition and the result is summarized in Table 3 . The optimal time of addition ofAmberlite XAD-8to the fermentation was at 24 hours, enhancing the titer of BMS-182123by 5.5 fold to 86.3 /jg/ml. When 1% Amberlite XAD-8 was added to the fermentor culture at 24 hours, the maximum titer of BMS-182123 achieved was 54.3/jg/ml at day 6 of the fermentation.
Isolation of BMS-182123 from
Fermentor Culture A 250-liter fermentor culture containing Amberlite XAD-8 (1%) was harvested and filtered. BMS-182123 was isolated from solids as shown in Fig. 2 either by monitoring the activity on LPS induction ofTNF-a from RAW264.7 macrophages or evaluated by TLC (silica gel 0.25mm, CHC13-CH3OH 95: 5) using short UV light for visualization. The recovered solids were extracted with butanol (57 liters). The butanol extract was evaporated in vacuo to dryness in a rotary evaporator to yield 360 g residue A. Residue A was dissolved in 1600ml of 10%aqueous methanol. The solution was extracted 3 times with hexane (1000ml each) and the hexane layer was removed. The remaining aqueous methanol phase was adjusted to 25%aqueous methanol and extracted 3 times with carbon tetrachloride (1000ml each) and a fourth time with 630 ml carbon tetrachloride, which had been previously saturated with 25% aqueous methanol. The carbon tetrachloride layer was evaporated to dryness in vacuo to yield 68.1 g residue B which was enriched in BMS-182123, Residue B was applied to a 2000-ml fritted filter funnel packed with 350 g of diatomaceous earth. Elution using in-house vacuumwas with cyclohexane followed by hexane, toluene, diethyl ether, ethyl acetate, acetonitrile, and methanol (1000ml each). Fig. 3 . Biological Activities BMS-182123 was tested in vitro for its ability to inhibit bacterial LPS induction and secretion of cytokine, TNF-a, from murine macrophages and humanperipheral blood monocytes. The results are summarized in Figs. 4~6. In the absence of LPS, the RAWmacrophages did not secrete detectable levels of TNF-a (Fig. 4) . LPS induced levels of TNF-a in the absence of BMS-182123 were used as the maxima. The highest concentrations of drug resulted in > 99% inhibition of LPS induced TNF-a (Fig. 4) . In these studies the effective BMS-182123 concentration (IC50) resulting in 50% inhibition of LPS-induced TNF-a was about 600 ng/ml. To verify that the compound was also active with native macrophages, cultures were established using murine peritoneal macrophages (thioglycolate-elicited) and the result is summarized in Fig. 4 . As seen with the RAWmacrophages, BMS-182123 inhibited LPS induction of TNF-a in the native murine macrophages. The IC50 under these assay conditions was about 500ng/ml. The effect of BMS-182123 on the secretion of TNF-a by human peripheral blood monocytes stimulated by LPS is shown TNF-a promoter activity, levels of TNF-a messenger RNA in the macrophages cultures were probed by
Northern analysis (Fig. 7) . Based on these results, it is clear that BMS-182123 at a concentration of 2/ig/ml significantly reduces the steady-state TNF-a mRNA expression induced by LPS. To determine if this decreased mRNA expression was caused by an increase in the post-transcriptional degradation, studies were performed in which the compoundwas not added to the cells until after mRNA levels were induced by LPS treatment. From these studies (Fig. 8) , there does not appear to be any changes in mRNA stability associated with the addition of BMS-182123 to the macrophages cultures. Thus, under these assay conditions, BMS-182123 does in fact appear to inhibit TNF-a gene transcription and not to alter post-transcriptional events.
Discussion
In this paper we described the fermentation and isolation of a metabolite from P. chrysogenum strain V39673, BMS-182123, which demonstrated in vitro inhibitory activity on the production of LPS-induced TNF-a from murine macrophages and human monocytes. Therefore BMS-182123 may be a potential candidate for development as an agent for treatment of septic shock and other TNF-a mediated pathophysiologic diseases. The structure of BMS-182123 is identical to trichodimerol which was isolated from T. longibrachiatum26). No biological activities have been reported for trichodimerol. The production of TNF-a can be regulated at many levels. Increased transcription accounts for a significant portion of the LPSinduction of TNF-a production; however, LPS also dramatically affects posttranscriptional control of mRNA abundance.
From these studies, it is evident that BMS-182123 results in a significant suppression of TNF-a protein apparently due to a decrease in gene transcription. This is supported by the observed suppression of the TNF-a promoter based assays, and the decrease in TNF-a mRNA steady state levels without any changes in the apparent mRNA stability.
The exact site of action where the drug intercedes to interrupt TNF-a gene transcription remains to be determined. In addition BMS-182123, at a concentration of 4//g/ml, did not show any nonspecific effects on protein synthesis as demonstrated by macrophages incorporation of 35S-methionine (over 2 hours) into acid precipitable protein, or constitutive secretion of lysozyme over a 24 hours period (data not shown). Therefore the inhibitory effect of BMS-182123 on the production of TNF-a is not due to nonspecific effects on cell functions.
LPS induced interleukin-1/?
(IL-1/?) secretion over a 4 hour interval was not abolished but was reduced by 25 to 50% (data not shown). Thus, there maybe some cross over in transduction signals between IL-1/? and TNF-a which are blocked by BMS-1 82123, or this maymerely reflect a reduction in autocrine induction ofIL-1/? by the macrophages' TNF-a. Whether or not BMS-182123 suppresses TNF-a induction by stimuli other than LPS remains to be determined.
Addition of resin to the fermentation not only enhanced the production of BMS-1 82123 but also provided an effective way for its scale-up production and purification. Before the studies of the effect of resin on the production of BMS-182123, the downstream processing from the fermentor culture was hindered by the presence of antifoam agents. Polypropylene glyeol P-2000 was found to be very effective in controlling the foaming in the fermentation of strain V39673. For a 10-liter fermentor cultivation of V39673, 30~40ml polypropylene glyeol was needed to suppress the foaming for the whole fermentation run. Polypropylene glyeol has a similar polarity to BMS-182123 and coupled to the low productivity in the fermentation, a very low recovery yield was obtained in the fermentor culture. Shifting to a more non-polar silicone-based antifoam agent Antifoam C Emulsion (Dow Corning) was attempted to aid the chromatographic separation of BMS-182123 from the silicone emulsion, however, the silicone emulsion was ineffective in controlling the foaming in the fermentation.
Significant amounts of silicone emulsion (350~400ml) were required to suppress the foaming in the 10-liter fermentor culture of strain V39673. Addition of such a large amount of antifoam led to a decrease in the production ofBMS-182123 and also presented a problem in removing such a large quantity of silicone emulsion in the downstream processing step. With addition of Amberlite XAD-8(1%) to the fermentor culture at 24 hours, the maximumtiter of 54.3 /zg/ml was achieved. By binding BMS-182123 to the resin, a large portion of polypropylene glyeol present in the fermentation can be removed before the extraction step and together with the increase in the production of BMS-182123 in the resinsupplemented fermentor culture (i.e. significant increase 
